937 related articles for article (PubMed ID: 35667465)
1. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.
Kumar V; Varghese S
Adv Healthc Mater; 2019 Feb; 8(4):e1801198. PubMed ID: 30516355
[TBL] [Abstract][Full Text] [Related]
3. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
[TBL] [Abstract][Full Text] [Related]
4. Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy.
Parlato S; Grisanti G; Sinibaldi G; Peruzzi G; Casciola CM; Gabriele L
Lab Chip; 2021 Jan; 21(2):234-253. PubMed ID: 33315027
[TBL] [Abstract][Full Text] [Related]
5. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer organoids and their applications for precision cancer immunotherapy.
Guan D; Liu X; Shi Q; He B; Zheng C; Meng X
World J Surg Oncol; 2023 Oct; 21(1):343. PubMed ID: 37884976
[TBL] [Abstract][Full Text] [Related]
7. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
8. Organ-on-Chip platforms to study tumor evolution and chemosensitivity.
Dsouza VL; Kuthethur R; Kabekkodu SP; Chakrabarty S
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188717. PubMed ID: 35304293
[TBL] [Abstract][Full Text] [Related]
9. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
Ringquist R; Ghoshal D; Jain R; Roy K
Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
[TBL] [Abstract][Full Text] [Related]
10. 3D cancer models: One step closer to
Manduca N; Maccafeo E; De Maria R; Sistigu A; Musella M
Front Immunol; 2023; 14():1175503. PubMed ID: 37114038
[TBL] [Abstract][Full Text] [Related]
11. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
Boucherit N; Gorvel L; Olive D
Front Immunol; 2020; 11():603640. PubMed ID: 33362787
[TBL] [Abstract][Full Text] [Related]
12. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy.
Wang J; Chen C; Wang L; Xie M; Ge X; Wu S; He Y; Mou X; Ye C; Sun Y
Front Oncol; 2022; 12():872531. PubMed ID: 35449581
[TBL] [Abstract][Full Text] [Related]
14. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
Magré L; Verstegen MMA; Buschow S; van der Laan LJW; Peppelenbosch M; Desai J
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37220953
[TBL] [Abstract][Full Text] [Related]
15. Organoid Models of Tumor Immunology.
Yuki K; Cheng N; Nakano M; Kuo CJ
Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
[TBL] [Abstract][Full Text] [Related]
16. Reconstructing the tumor architecture into organoids.
Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
[TBL] [Abstract][Full Text] [Related]
17. On-chip recapitulation of the tumor microenvironment: A decade of progress.
Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
[TBL] [Abstract][Full Text] [Related]
18. Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology.
Xie H; Appelt JW; Jenkins RW
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885161
[TBL] [Abstract][Full Text] [Related]
19. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Microenvironment: An Introduction to the Development of Microfluidic Devices.
Kundu B; Caballero D; Abreu CM; Reis RL; Kundu SC
Adv Exp Med Biol; 2022; 1379():115-138. PubMed ID: 35760990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
